Icahn School of Medicine at Mount Sinai
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Icahn School of Medicine at Mount Sinai sits in the top decile of US sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count).
Icahn School of Medicine at Mount Sinai: 708 sponsored US clinical trials, 163 recruiting.
Icahn School of Medicine at Mount Sinai sponsors 708 registered US clinical trials on ClinicalTrials.gov, 163 of them currently recruiting, and 423 completed. 88 of these trials are in Phase 3-4 (later-stage) and 138 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 7 trials.
Top-decile sponsor footprint
Icahn School of Medicine at Mount Sinai ranks in the top decile of sponsors by registered trial count (#48 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
423 of 499 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
708 total, page 12 of 15
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
NCT03914417
Abiraterone Acetate Trial in African American Prostate Cancer Patients
NCT01735396
A Smoking Intervention Study Using Scheduled Gradual Reduction With Varenicline to Help With Cessation
NCT01772641
The Effect of EMT on Anxiety Levels and Perception of Waiting Time in the Radiation Oncology Waiting Room
NCT03660319
Online Emotional Regulation Group Treatment
NCT01730261
Treatment of Post-Traumatic Brain Injury (Post-TBI) Fatigue With Light Therapy
NCT01725750
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities
NCT01544374
Imaging Stimulant and Non Stimulant Treatments for ADHD: A Network Based Approach
NCT01678209
Detection of C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus
NCT02131675
CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma
NCT01740401
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
NCT01658150
Cerebral Oxygen Monitoring During Surgery and Recovery After Surgery in Patients Having Lung Surgery
NCT01835327
Does a Transabdominal Plane Block Decrease Patient Pain After Ventral Hernia Repair?
NCT02007096
Tissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) Patients
NCT01970930
A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department
NCT01654887
Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosocial Impact
NCT01688895
A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers
NCT01454817
Immune Monitoring on Sipuleucel-T
NCT02237170
Systane Ultra Versus Maxidex Versus Saline
NCT01775540
Improving Colorectal Cancer Screening for Diverse Hispanics in Urban Primary Care
NCT01569620
A Trial Assessing the Effectiveness of Text Messages in Improving Continuation of Birth Control
NCT01545609
Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart
NCT01961323
Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition
NCT01582217
Clinical Trial in 22q13 Deletion Syndrome(Phelan-McDermid Syndrome)
NCT01525901
The xDAPT External Validation Study
NCT06736626
Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI
NCT05132062
Treating Cancer-Related Fatigue Through Systematic Light Exposure
NCT01873794
Does Continued Use of Clopidogrel Into Surgery Cause Increased Perioperative Bleeding?
NCT01960296
World Trade Center (WTC) CHEST
NCT01466218
Measuring and Treating Brain Oxygen Levels in Open Heart Surgery
NCT01539382
Bioavailability and Biological Effects of Vitamin D2 Contained in Mushroom
NCT01488734
Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates
NCT01517958
Non-Invasive Imaging of Atherosclerosis
NCT01418313
Effect of Paracervical Block on Post Operative Pain in Laparoscopic Gynecologic Surgery
NCT01534416
An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations
NCT01459744
Changes in the Brain as Borderline Patients Learn to Regulate Their Emotions
NCT02465697
Treatment of External Genital Warts With Cryotherapy and Sinecatechins 15% Ointment
NCT02147353
Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates
NCT01420029
MRI Studies of Emotion in Depression
NCT02429011
Proactive Palliative Care for Patients With Ventricular Assist Devices (VAD) and Their Families
NCT01427634
Peer Patient Navigation for Colon Cancer Screening
NCT02194959
Improving Pain Management for Older Adults in the Emergency Department (ED)
NCT01962610
Minocycline for Bipolar Depression
NCT01514422
Identification of Early Predictors of Fetomaternal Hemorrhage
NCT01232387
Emergency Department-Based Palliative Care for Advanced Cancer Patients
NCT01358110
Computerized Cognitive Intervention in the Oldest-Old
NCT03397498
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
NCT01709695
Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma
NCT01342172
Project PARIS: Parents and Residents in Session
NCT01299974
Will a Real Time Advisory for Double Low State Change Clinical Behavior and Impact Outcomes
NCT01545596
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 57 |
| Phase 2 | 81 |
| Phase 3 | 21 |
| Phase 4 | 67 |
Therapeutic Areas
What is open in the Icahn School of Medicine at Mount Sinai pipeline
163 recruiting of 708 indexed (23% open); 423 completed (60%).
Phase mix: 88 late (III/IV) vs 138 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Icahn School of Medicine at Mount Sinai: open-pipeline peers nationwide
Peers matched on 708 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Icahn School of Medicine at Mount Sinai sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 708 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
- University of Miami · 721 trials · 20% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
- Rahul Aggarwal · 23% recruiting · 13 trials
- Sequenom · 23% recruiting · 26 trials
Related
What to do with this Icahn School of Medicine at Mount Sinai page
708 registered trials is a research-attention snapshot, not an endorsement of Icahn School of Medicine at Mount Sinai or any single study.
- 163 of Icahn School of Medicine at Mount Sinai's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition Icahn School of Medicine at Mount Sinai studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Icahn School of Medicine at Mount Sinai pipeline card: 708 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.